Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHeimisdottir, Alexandra A
MetadataShow full item record
CitationHeimisdottir AA, Enger E, Morelli S, et al. Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG [published online ahead of print, 2020 Apr 11]. Gen Thorac Cardiovasc Surg. 2020;10.1007/s11748-020-01353-y. doi:10.1007/s11748-020-01353-y
AbstractObjectives: Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed antidepressants worldwide. Studies suggest that SSRI/SNRIs can increase bleeding following different surgical procedures, including open heart surgery, but results are conflicting. The objective of this study was to analyse their effects on bleeding after coronary artery bypass grafting (CABG). Methods: Of 1237 patients that underwent CABG in Iceland in 2007-2016, 97 (7.8%) used SSRIs/SNRIs preoperatively and were compared to a reference group (n = 1140). Bleeding was assessed using 24-h chest-tube output, number of RBC units transfused and reoperation for bleeding. Thirty-day mortality rates and incidence of complications were also compared. Results: The two groups were comparable with respect to preoperative and operative variables, with the exception of BMI being significantly higher in the SSRI/SNRI group (30.2 vs. 28.3 kg/m2, p < 0.001). No significant differences were observed between groups in 24-h chest-tube output [815 (SSRI/SNRI) vs. 877 ml (reference), p = 0.26], number of RBC units transfused (2.2 vs. 2.2, p = 0.99) or the rate of reoperation for bleeding (4.1% vs. 6.0%, p = 0.61). The incidences of complications and 30-day mortality rate were also similar. Conclusions: Using three different criteria, preoperative use of SSRIs/SNRIs was not shown to increase bleeding after CABG. Furthermore, short-term complications as well as 30-day mortality rates did not differ from those of controls. Thus, temporary cessation of SSRI/SNRI treatment prior to CABG to decrease the risk of bleeding is unwarranted.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
- Authors: Smith MM, Smith BB, Lahr BD, Nuttall GA, Mauermann WJ, Weister TJ, Dearani JA, Barbara DW
- Issue date: 2018 Jun
- Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.
- Authors: Xiong GL, Jiang W, Clare RM, Shaw LK, Smith PK, O'Connor CM, Ranga K, Krishnan R, Kristin Newby L
- Issue date: 2010 Jun
- Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
- Authors: Tully PJ, Cardinal T, Bennetts JS, Baker RA
- Issue date: 2012 Apr
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
- Authors: Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L
- Issue date: 2015 Apr 1
- Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
- Authors: Clayton AH, Baker RA, Sheehan JJ, Cain ZJ, Forbes RA, Marler SV, Marcus R, Berman RM, Thase ME
- Issue date: 2014 Jul 18